• ALDOB K87 Lactylation Orchestrates Mitochondrial Fission in

  2026-06-11

  Yi et al. (2026) reveal that ALDOB K87 lactylation directly drives mitochondrial fission and metabolic reprogramming in pulmonary hypertension (PH), linking metabolic shifts to vascular pathology in smooth muscle cells. Their findings establish a lactate–ALDOB–DRP1 axis as a novel target for modulating abnormal PASMC proliferation and PH progression.

• IP3R/Ca2+/STAT3 Pathway Mediates Nanoplastic–Cadmium Apoptos

  2026-06-10

  This study uncovers how co-exposure to polystyrene nanoplastics and cadmium synergistically induces apoptosis in intestinal cells via the IP3R/Ca2+/STAT3 signaling axis. The mechanistic insights clarify environmental co-contaminant toxicity and provide a molecular foundation for targeted calcium signaling modulation in toxicology research.

• Alda 1: Unlocking ALDH2-Driven Cardiac Regeneration Pathways

  2026-06-10

  Explore how Alda 1, a leading ALDH2 activator, goes beyond cardioprotection by driving cardiomyocyte proliferation and regeneration. This article delivers new insights for researchers in cardiac ischemia, heart failure, and aldehyde detoxification.

• NSC 87877 Shp2 Inhibitor: Applied Workflows for Neuroinflamm

  2026-06-09

  NSC 87877 empowers researchers to selectively block the Shp2 signaling pathway, enabling precise mechanistic studies in neuroinflammation, cancer, and pain. This guide distills best practices, workflow enhancements, and troubleshooting strategies—leveraging the latest evidence to maximize the compound’s impact in experimental systems.

• USP7 Controls Macrophage Polarization via PKM2 in Pancreatit

  2026-06-09

  This study uncovers how ubiquitin-specific protease 7 (USP7) drives the pro-inflammatory polarization of macrophages in severe acute pancreatitis by regulating pyruvate kinase M2 (PKM2)-mediated metabolic reprogramming. The findings highlight the therapeutic potential of targeting PKM2 to modulate immune responses in inflammatory diseases.

• Mechanistic Precision in cDNA Synthesis: Strategic Value for

  2026-06-08

  This thought-leadership article dissects the mechanistic innovations behind the HyperScript™ First-Strand cDNA Synthesis Kit, guiding translational researchers through the biological, experimental, and strategic dimensions of high-fidelity cDNA synthesis. Drawing from recent advances in biopolymer scaffolds and complex transcriptome analysis, we situate APExBIO’s HyperScript technology at the intersection of mechanistic rigor and clinical ambition, offering a forward-looking perspective on next-generation gene expression workflows.

• Alda 1: ALDH2 Activator for Cardiac Ischemia Research Workfl

  2026-06-08

  Alda 1, from APExBIO, uniquely boosts both wild-type and mutant ALDH2 activity, enabling robust cardiac ischemia and regeneration studies—even in models with the ALDH2*2 variant. Discover stepwise protocols, troubleshooting guidance, and translational insights from recent breakthroughs.

• CDC42–YAP–mTOR Axis Regulates Intestinal Stem Cell Fate Deci

  2026-06-07

  Zhang et al. uncover how CDC42-driven epithelial polarity dictates the fate transition between intestinal stem cells and transit amplifying cells through a Hippo-YAP-EGF-mTOR signaling cascade, independent of canonical Wnt signaling. These findings refine our understanding of gastrointestinal epithelial homeostasis and offer a mechanistic foundation for future research into stem cell regulation and tissue regeneration.

• Dorsomorphin (Compound C): Precision Inhibition for Metaboli

  2026-06-06

  Dorsomorphin (Compound C) stands out as a dual AMPK and BMP pathway inhibitor with unmatched selectivity, empowering researchers to dissect metabolic, autophagic, and differentiation signaling. This guide delivers actionable protocols, troubleshooting advice, and context from cutting-edge literature—enabling optimized workflows in cell-based and animal models.

• AZD0156 and the Precision Modulation of ATM Signaling in Can

  2026-06-05

  Explore how AZD0156, a next-generation ATM kinase inhibitor, enables advanced cancer therapy research by precisely targeting DNA damage response pathways. This article reveals new assay strategies and practical insights beyond conventional approaches.

• NF-κB/Apaf1/Caspase-9 Axis in Septic AKI: Pathway and Implic

  2026-06-05

  This study uncovers the pivotal role of the NF-κB/Apaf1/caspase-9 signaling axis in promoting inflammation and apoptosis in septic acute kidney injury (AKI) by suppressing autophagy. These findings clarify the mechanistic link between inflammatory signaling and tubular cell injury, offering new avenues for targeted intervention in septic AKI.

• Annexin-V Detection of Cardiomyocyte Death After Ischemia/Re

  2026-06-04

  This paper establishes recombinant human annexin-V as a sensitive in situ marker for early cardiomyocyte death in a mouse model of myocardial ischemia/reperfusion (I/R). Its findings refine the temporal mapping of cell death and support evaluation of cell death–blocking strategies, providing a methodological advance for preclinical cardiovascular research.

• Anti-HMGB1 Rabbit Monoclonal Antibody: Technical Workflow Gu

  2026-06-04

  The Anti-HMGB1 Rabbit Monoclonal Antibody (SKU MA3057) enables specific detection of HMGB1 protein in human, mouse, and rat samples via Western blot, immunohistochemistry, and flow cytometry. It is intended for research use only and not validated for diagnostic or therapeutic applications. Users should apply protocol parameters and storage recommendations to ensure reproducibility.

• Diterpene Glycosides from Fructus Rubi Target Androgen Signa

  2026-06-03

  The referenced study demonstrates that diterpene glycosides extracted from Fructus Rubi effectively ameliorate benign prostatic hyperplasia (BPH) in rat models by modulating both androgen receptor and TGF-β/Smad signaling pathways. These findings advance our mechanistic understanding of androgen-driven prostate pathology and offer a multitarget approach for BPH intervention.

• Ciprofloxacin for Precision Antibacterial Assays: Mechanism

  2026-06-03

  Explore how Ciprofloxacin, a potent fluoroquinolone antibiotic, advances precision antibacterial assays by integrating the latest research on resistance gene transmission and assay optimization. This article uniquely bridges molecular mechanisms with nuanced protocol design for next-generation research.

436 records 14/30 page Previous Next First page 上5页 1112131415 下5页 Last page